Tag: Phase IIb

Celixir’s cell therapy gets green light for heart failure trial

by Selina McKee | Jan 9, 2018 | News | 0

The Medicines and Healthcare Products Regulatory Agency has issued a green light allowing Celixir to carry out a potentially pivotal Phase IIb human clinical trial with its stem cell therapy Heartcel.

Verona Pharma begins dosing RPL554 in Phase IIb COPD trial

by Selina McKee | Jul 26, 2017 | News | 0

Patients have begun receiving Verona Pharma’s experimental respiratory drug RPL554 in a Phase IIb trial assessing its potential as a maintenance therapy for chronic obstructive pulmonary disease (COPD).